Volume 383, Issue 9925, Pages (April 2014)

Slides:

Advertisements

Similar presentations

Future challenges for clinical care of an ageing population infected with HIV: a modelling study Dr Mikaela Smit, PhD, Kees Brinkman, MD, Suzanne Geerlings,

Advertisements

Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4·4 million participants The Lancet Volume 387, Issue 10027,

Date of download: 7/5/2016 Copyright © The American College of Cardiology. All rights reserved. From: Early Aldosterone Blockade in Acute Myocardial Infarction:

Volume 389, Issue 10081, Pages (May 2017)

Microvascular disease and risk of cardiovascular events among individuals with type 2 diabetes: a population-level cohort study Dr Jack R W Brownrigg,

Volume 386, Issue 10006, Pages (November 2015)

Prognostic Value of Total Bilirubin in Patients With ST-Segment Elevation Acute Myocardial Infarction Undergoing Primary Coronary Intervention Mehmet.

The outcome of primary percutaneous coronary intervention for stent thrombosis causing ST-elevation myocardial infarction Mehmet Ergelen, MD, Sevket.

Tight Blood Glucose Control With Insulin in the ICU

Volume 385, Issue 9985, Pages (June 2015)

Copyright © 2005 American Medical Association. All rights reserved.

Does Diabetes Mellitus Abolish the Beneficial Effect of Primary Coronary Angioplasty on Long-term Risk of Reinfarction After Acute ST-Segment Elevation.

Type 2 diabetes and incidence of cardiovascular diseases: a cohort study in 1·9 million people Dr Anoop Dinesh Shah, MRCP, Claudia Langenberg, PhD, Eleni.

Volume 386, Issue 9992, Pages (August 2015)

Improved Outcomes in Patients with Non-ST-Elevation Myocardial Infarction during 20 Years are Related to Implementation of Evidence-based Treatments –

Copyright © 2009 American Medical Association. All rights reserved.

R. Jay Widmer, MD, PhD, Peter M. Pollak, MD, Malcolm R

Volume 383, Issue 9920, Pages (March 2014)

Volume 84, Issue 2, Pages (August 2013)

Volume 11, Issue 6, Pages (June 2012)

Depression and violence: a Swedish population study

Volume 382, Issue 9902, Pages (October 2013)

Quality of Care in Chinese Hospitals: Processes and Outcomes After ST-segment Elevation Myocardial Infarction Nicholas S. Downing, MD; Yongfei Wang, MS;

Volume 384, Issue 9952, Pages (October 2014)

Baseline characteristics of patients

Figure 3 Ischaemic outcomes in the ST-segment elevation myocardial

European Heart Association Journal 2007 April

Volume 386, Issue 10012, Pages (December 2015)

Effects of the introduction of new vaccines in Guinea-Bissau on vaccine coverage, vaccine timeliness, and child survival: an observational study Dr Ane.

Volume 14, Issue 4, Pages (April 2015)

Recent Temporal Trends in the Presentation, Management, and Outcome of Women Hospitalized with Acute Coronary Syndromes Avi Sabbag, MD, Shlomi Matetzky,

Figure 2 Ischaemic and bleeding outcomes in the major clinical trials

Peter K. Smith, MD, Michel Carrier, MD, John C

Figure 1 PCI strategies in patients with STEMI and multivessel disease

Kay Lee Park, MD, Robert J. Goldberg, PhD, Frederick A

Volume 382, Issue 9902, Pages (October 2013)

J. Trevor Posenau, MD, Daniel M. Wojdyla, MS, Linda K

Contemporary cardiovascular risk and secondary preventive drug treatment patterns in peripheral artery disease patients undergoing revascularization

Cardiovascular outcomes in patients with peripheral arterial disease as an initial or subsequent manifestation of atherosclerotic disease: Results from.

Volume 13, Issue 4, Pages (April 2014)

Volume 383, Issue 9920, Pages (March 2014)

Characteristics of Contemporary Patients Discharged From the Hospital After an Acute Coronary Syndrome Robert J. Goldberg, PhD, Jane S. Saczynski, PhD,

Volume 391, Issue 10120, Pages (February 2018)

John P. Vavalle, MD, MHS, Renato D. Lopes, MD, PhD, Anita Y

Risk of reproductive complications following chlamydia testing: a population-based retrospective cohort study in Denmark Dr Bethan Davies, PhD, Katy.

Early and long-term outcomes of coronary artery bypass grafting in patients with acute coronary syndrome versus stable angina pectoris Toshihiro Fukui,

Volume 386, Issue 9992, Pages (August 2015)

Measure-specific reasons for exclusion (2010-Q4–2013-Q3).

Volume 385, Issue 9985, Pages (June 2015)

Consequence of reimbursement policy alteration for urgent PCI in Japan

Volume 79, Issue 9, Pages (May 2011)

Type 2 diabetes and incidence of cardiovascular diseases: a cohort study in 1·9 million people Dr Anoop Dinesh Shah, MRCP, Claudia Langenberg, PhD, Eleni.

Volume 378, Issue 9786, Pages (July 2011)

Volume 2, Issue 5, Pages (May 2015)

Volume 12, Issue 8, Pages (August 2013)

Age-dependent care and long-term (20year) mortality of 14,434 myocardial infarction patients: Changes from 1985 to 2008 Sjoerd T. Nauta, Jaap W. Deckers,

Jennifer Tjia, MD, MSCE, Jeroan Allison, MD, Jane S

Volume 2, Issue 10, Pages (October 2015)

Shannon M. Dunlay, MD, MS, Quinn R. Pack, MD, Randal J

Reinfarction in Patients with Myocardial Infarction with Nonobstructive Coronary Arteries (MINOCA): Coronary Findings and Prognosis Anna M. Nordenskjöld,

Acute coronary syndromes: diagnosis

Adjunctive Therapies in the Treatment of Acute Coronary Syndromes

Contemporary cardiovascular risk and secondary preventive drug treatment patterns in peripheral artery disease patients undergoing revascularization

MRRs and EMRRs for women with ACS

A model of variation and accelerating factors in the process of acute care chain of patients with STEMI going for primary PCI. PCI, percutaneous coronary.

Kaplan-Meier curves for the end point all-cause mortality in the total patient population stratified according to complete/incomplete revascularisation.

Use of evidence-based cardiac medications before, during and after hospitalisation for the index event in (A) overall ACS population and (B) patients with.

R. Jay Widmer, MD, PhD, Peter M. Pollak, MD, Malcolm R

Secular trends in cardiovascular disease mortality, incidence, and case fatality rates in adults in the United States Ahmet Ergin, MD, PhD, MPH, Paul.

Kaplan-Meier curve of the primary outcome in patients prescribed ACE inhibitor (ACEI) and angiotensin receptor blocker (ARB). Kaplan-Meier curve of the.

Presentation transcript:

Volume 383, Issue 9925, Pages 1305-1312 (April 2014) Acute myocardial infarction: a comparison of short-term survival in national outcome registries in Sweden and the UK Sheng-Chia Chung, PhD, Rolf Gedeborg, MD, Owen Nicholas, PhD, Stefan James, MD, Prof Anders Jeppsson, MD, Prof Charles Wolfe, MD, Peter Heuschmann, MD, Prof Lars Wallentin, MD, Prof John Deanfield, FRCP, Prof Adam Timmis, FRCP, Dr Tomas Jernberg, MD, Prof Harry Hemingway, FRCP The Lancet Volume 383, Issue 9925, Pages 1305-1312 (April 2014) DOI: 10.1016/S0140-6736(13)62070-X Copyright © 2014 Chung et al. Open Access article distributed under the terms of CC BY Terms and Conditions

Figure 1 Study population AMI=acute myocardial infarction. ID=identifier. The Lancet 2014 383, 1305-1312DOI: (10.1016/S0140-6736(13)62070-X) Copyright © 2014 Chung et al. Open Access article distributed under the terms of CC BY Terms and Conditions

Figure 2 Use of reperfusion or fibrinolysis to treat STEMI and medication at discharge among all patients, by year (A) Primary PCI and (B) fibrinolysis, including any given before admission or in hospital. (C) Any antiplatelet therapy and statin and (D) use of β blockers and ACEI or ARBs among all acute myocardial infarction patients who survived to discharge. STEMI=ST-segment-elevation myocardial infarction. PCI=percutaneous coronary intervention. ACEI=angiotensin-converting-enzyme inhibitor. ARB=angiotensin-receptor blocker. The Lancet 2014 383, 1305-1312DOI: (10.1016/S0140-6736(13)62070-X) Copyright © 2014 Chung et al. Open Access article distributed under the terms of CC BY Terms and Conditions

Figure 3 Kaplan-Meier curves for cumulative mortality at 30 days after admission with acute myocardial infarction in Sweden and the UK *Time of censoring or vital status at 30 days missing for 129 patients in the UK. The Lancet 2014 383, 1305-1312DOI: (10.1016/S0140-6736(13)62070-X) Copyright © 2014 Chung et al. Open Access article distributed under the terms of CC BY Terms and Conditions

Figure 4 30-day mortality of UK patients admitted in each study year, standardised according to the Swedish casemix model p=0·01 for linear trend across years for the relative risks. AMI=acute myocardial infarction. The Lancet 2014 383, 1305-1312DOI: (10.1016/S0140-6736(13)62070-X) Copyright © 2014 Chung et al. Open Access article distributed under the terms of CC BY Terms and Conditions